Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.34 |
| ▸ | ACE | P12821 | 2/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 8/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL786957 | 0.85 | MME (0.37) | MMEACELTB4RTBXAS1CYP1A2 | |
| SCHEMBL13042934 | 0.80 | CPA1 (0.37) | LTA4H | |
| SCHEMBL786837 | 0.80 | CYP1A2 (0.37) | CYP1A2LTA4H | |
| SCHEMBL13042932 | 0.72 | MMP12 (0.31) | — | |
| SCHEMBL14586568 | 0.71 | NPC1 (0.30) | — | |
| SCHEMBL18227249 | 0.68 | HDAC3 (0.41) | HDAC3HDAC4HDAC1HDAC2HDAC10 | |
| SCHEMBL786853 | 0.68 | FFAR4 (0.50) | CYP1A2HDAC11NPSR1MAPT | |
| SCHEMBL1054764 | 0.67 | TSHR (0.52) | HDAC11 | |
| SCHEMBL2763157 | 0.65 | CYP1A2 (0.67) | CYP1A2HDAC11LTA4H | |
| SCHEMBL21998 | 0.65 | CYP1A2 (0.67) | CYP1A2HDAC11LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150166342-A1 | Functionalized Matrices for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2015-06-18 | — | — | US | disclosed |
| US-8916064-B2 | Functionalized matrices for dispersion of nanostructures | NANOSYS, INC. (US) | 2014-12-23 | — | — | US | disclosed |
| US-20140151600-A1 | Functionalized Matrices for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-20130043433-A1 | Functionalized Matrixes for Dispersion of Nanostructures | NANOSYS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20120068118-A1 | NANOCRYSTAL DOPED MATRIXES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120068118-A1 | NANOCRYSTAL DOPED MATRIXES | STRA6, EPHA6, PIR | MME 129/4885ACE 587/4885LTB4R 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.